Trade :
Stage set for text-based negotiations on revised TRIPS waiver at WTO (PRIV)
(D. Ravi Kanth, Washington DC)
The 62 co-sponsors of the proposed TRIPS waiver at the WTO for combating the worsening COVID-19 pandemic have sought at least three years for waiving intellectual property rights "on health products and technologies, including diagnostics, therapeutics, vaccines, medical devices, personal protective equipment, their materials, or components, and their methods and means of manufacture for the prevention, treatment, and containment of COVID-19."
|